Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
Recruiting · NCT05540938 · Registry updated 2025-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 4 | 2025-01-20 | NCT05540938 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China-Japan Friendship Hospital | Beijing | China | 22 |